{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:19:00Z","timestamp":1789503540394,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015956","name":"Special Project for Research and Development in Key areas of Guangdong Province","doi-asserted-by":"publisher","award":["2020B1111100004"],"award-info":[{"award-number":["2020B1111100004"]}],"id":[{"id":"10.13039\/501100015956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174156,82374239,82405259"],"award-info":[{"award-number":["82174156,82374239,82405259"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.phrs.2026.108196","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:17:58Z","timestamp":1776172678000},"page":"108196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["SIRT4-mediated debutyrylation of SUCLG1 rescues myocardial energy failure in HFpEF: Ginsenoside Rb3 as a novel SIRT4-interacting regulator"],"prefix":"10.1016","volume":"227","author":[{"given":"Xiaohan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenfan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1105-0495","authenticated-orcid":false,"given":"Yuanyuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108196_bib1","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","article-title":"Epidemiology of heart failure: a contemporary perspective","volume":"128","author":"Roger","year":"2021","journal-title":"Circ. Res"},{"key":"10.1016\/j.phrs.2026.108196_bib2","first-page":"e895","article-title":"AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.108196_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002883","article-title":"Risk factors for incident hospitalized heart failure with preserved versus reduced ejection fraction in a multiracial cohort of postmenopausal women","volume":"9","author":"Eaton","year":"2016","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.phrs.2026.108196_bib4","article-title":"Comparison of pharmacological treatment effects on long-time outcomes in heart failure with preserved ejection fraction: a network meta-analysis of randomized controlled trials","volume":"12","author":"Lin","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2026.108196_bib5","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jacbts.2021.12.009","article-title":"Clinical phenotypes of heart failure with preserved ejection fraction to select preclinical animal models","volume":"7","author":"van Ham","year":"2022","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.phrs.2026.108196_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pharmthera.2017.08.001","article-title":"Cardiac metabolism - A promising therapeutic target for heart failure","volume":"182","author":"Noordali","year":"2018","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.phrs.2026.108196_bib7","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.108196_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4070\/kcj.2020.0303","article-title":"Sodium\/glucose Co-transporter 2 inhibitor, empagliflozin, alleviated transient expression of SGLT2 after myocardial infarction","volume":"51","author":"Lee","year":"2021","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.phrs.2026.108196_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12933-021-01252-3","article-title":"Angiotensin II-induced upregulation of SGLT1 and 2 contributes to human microparticle-stimulated endothelial senescence and dysfunction: protective effect of gliflozins","volume":"20","author":"Park","year":"2021","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.phrs.2026.108196_bib10","doi-asserted-by":"crossref","first-page":"H1538","DOI":"10.1152\/ajpheart.00281.2004","article-title":"Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation","volume":"287","author":"Chandler","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2026.108196_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.yjmcc.2007.11.006","article-title":"The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover","volume":"44","author":"O'Donnell","year":"2008","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.phrs.2026.108196_bib12","doi-asserted-by":"crossref","first-page":"215re3","DOI":"10.1126\/scitranslmed.3007328","article-title":"Metabolic rates of ATP transfer through creatine kinase (CK Flux) predict clinical heart failure events and death","volume":"5","author":"Bottomley","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2026.108196_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fcvm.2018.00068","article-title":"Loss of metabolic flexibility in the failing heart","volume":"5","author":"Karwi","year":"2018","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.phrs.2026.108196_bib14","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart--an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.108196_bib15","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.apsb.2020.10.007","article-title":"Energy metabolism disorders and potential therapeutic drugs in heart failure","volume":"11","author":"He","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2026.108196_bib16","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1093\/cvr\/cvac166","article-title":"Cardiac metabolism in HFpEF: from fuel to signalling","volume":"118","author":"Capone","year":"2023","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.phrs.2026.108196_bib17","article-title":"The role of posttranslational modification and mitochondrial quality control in cardiovascular diseases","volume":"2021","author":"Liu","year":"2021","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.phrs.2026.108196_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fphys.2014.00301","article-title":"Metabolism leaves its mark on the powerhouse: recent progress in post-translational modifications of lysine in mitochondria","volume":"5","author":"Papanicolaou","year":"2014","journal-title":"Front Physiol."},{"key":"10.1016\/j.phrs.2026.108196_bib19","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1074\/mcp.M117.067553","article-title":"The landscape of histone modifications in a high-fat diet-induced obese (DIO) mouse model","volume":"16","author":"Nie","year":"2017","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.phrs.2026.108196_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe2771","article-title":"The regulatory enzymes and protein substrates for the lysine \u03b2-hydroxybutyrylation pathway","volume":"7","author":"Huang","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2026.108196_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.yjmcc.2021.12.015","article-title":"Mitochondrial protein hyperacetylation underpins heart failure with preserved ejection fraction in mice","volume":"165","author":"Liu","year":"2022","journal-title":"J. Mol. Cell Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108196_bib22","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.2337\/db06-S003","article-title":"Fatty acid signaling in the beta-cell and insulin secretion","volume":"55","author":"Nolan","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2026.108196_bib23","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1074\/mcp.M700021-MCP200","article-title":"Lysine propionylation and butyrylation are novel post-translational modifications in histones","volume":"6","author":"Chen","year":"2007","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.phrs.2026.108196_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101249","article-title":"Histone H3K9 butyrylation is regulated by dietary fat and stress via an Acyl-CoA dehydrogenase short chain-dependent mechanism","volume":"53","author":"Yang","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.phrs.2026.108196_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41421-023-00570-y","article-title":"Lysine butyrylation of HSP90 regulated by KAT8 and HDAC11 confers chemoresistance","volume":"9","author":"He","year":"2023","journal-title":"Cell Discov."},{"key":"10.1016\/j.phrs.2026.108196_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00431-009-1007-z","article-title":"A novel missense mutation in SUCLG1 associated with mitochondrial DNA depletion, encephalomyopathic form, with methylmalonic aciduria","volume":"169","author":"Ostergaard","year":"2010","journal-title":"Eur. J. Pedia"},{"key":"10.1016\/j.phrs.2026.108196_bib27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.mito.2010.03.003","article-title":"Marked mitochondrial DNA depletion associated with a novel SUCLG1 gene mutation resulting in lethal neonatal acidosis, multi-organ failure, and interrupted aortic arch","volume":"10","author":"Rivera","year":"2010","journal-title":"Mitochondrion"},{"key":"10.1016\/j.phrs.2026.108196_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2010.03.035","article-title":"Effect of ginsenoside Rb3 on myocardial injury and heart function impairment induced by isoproterenol in rats","volume":"636","author":"Wang","year":"2010","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2026.108196_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109487","article-title":"Ginsenoside Rb3 regulates energy metabolism and apoptosis in cardiomyocytes via activating PPAR\u0251 pathway","volume":"120","author":"Chen","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2026.108196_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108196_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.freeradbiomed.2021.02.041","article-title":"Mitochondrial redox and TCA cycle metabolite signaling in the heart","volume":"166","author":"Vujic","year":"2021","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.phrs.2026.108196_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1203\/PDR.0b013e3181e5c3a4","article-title":"Succinyl-CoA ligase deficiency: a mitochondrial hepatoencephalomyopathy","volume":"68","author":"Van Hove","year":"2010","journal-title":"Pedia Res"},{"key":"10.1016\/j.phrs.2026.108196_bib33","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.bbrc.2016.12.105","article-title":"Deficiency of succinyl-CoA synthetase \u03b1 subunit delays development, impairs locomotor activity and reduces survival under starvation in Drosophila","volume":"483","author":"Quan","year":"2017","journal-title":"Biochem Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2026.108196_bib34","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1021\/acs.jmedchem.3c01496","article-title":"Specific inhibitors of mitochondrial deacylase sirtuin 4 endowed with cellular activity","volume":"67","author":"Pannek","year":"2024","journal-title":"J. Med Chem."},{"key":"10.1016\/j.phrs.2026.108196_bib35","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.3390\/ijms23084195","article-title":"Remodeling and fibrosis of the cardiac muscle in the course of obesity-pathogenesis and involvement of the extracellular Matrix","volume":"23","author":"Kruszewska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108196_bib36","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1161\/CIRCULATIONAHA.119.042267","article-title":"Female sex is protective in a preclinical model of heart failure with preserved ejection fraction","volume":"140","author":"Tong","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.108196_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018574","article-title":"Sex differences in heart failure with preserved ejection fraction","volume":"10","author":"Sotomi","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2026.108196_bib38","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jacc.2009.09.065","article-title":"Sex-related differences in myocardial remodeling","volume":"55","author":"Piro","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2026.108196_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamacardio.2019.4150","article-title":"Sex differences in cardiometabolic traits and determinants of exercise capacity in heart failure with preserved ejection fraction","volume":"5","author":"Lau","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.phrs.2026.108196_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102467","article-title":"Insights into the post-translational modifications in heart failure","volume":"100","author":"Zhang","year":"2024","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.phrs.2026.108196_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cmet.2013.07.002","article-title":"Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure","volume":"18","author":"Karamanlidis","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2026.108196_bib42","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/CIRCULATIONAHA.116.022495","article-title":"Normalization of NAD+ redox balance as a therapy for heart failure","volume":"134","author":"Lee","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.108196_bib43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.33594\/000000151","article-title":"Mitochondrial hyperacetylation in the failing hearts of obese patients mediated partly by a reduction in SIRT3: the involvement of the mitochondrial permeability transition pore","volume":"53","author":"Castillo","year":"2019","journal-title":"Cell Physiol. Biochem"},{"key":"10.1016\/j.phrs.2026.108196_bib44","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/cvr\/cvu156","article-title":"Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling","volume":"103","author":"Alrob","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.phrs.2026.108196_bib45","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2337\/db06-0062","article-title":"Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects","volume":"55","author":"Bandyopadhyay","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2026.108196_bib46","doi-asserted-by":"crossref","first-page":"835","DOI":"10.18632\/aging.100616","article-title":"SIRT4 regulates ATP homeostasis and mediates a retrograde signaling via AMPK","volume":"5","author":"Ho","year":"2013","journal-title":"Aging"},{"key":"10.1016\/j.phrs.2026.108196_bib47","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1016\/j.bmc.2018.07.031","article-title":"SIRT4 is the last puzzle of mitochondrial sirtuins","volume":"26","author":"Li","year":"2018","journal-title":"Biorg Med. Chem."},{"key":"10.1016\/j.phrs.2026.108196_bib48","article-title":"Sirtuin 4 accelerates heart failure development by enhancing reactive oxygen species-mediated profibrotic transcriptional signaling","volume":"12","author":"Byrne","year":"2025","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.phrs.2026.108196_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70741","article-title":"Sirt4 deficiency promotes cardiomyocyte proliferation and cardiac repair","volume":"29","author":"Liu","year":"2025","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.phrs.2026.108196_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2022.153119","article-title":"SIRT4 suppresses doxorubicin-induced cardiotoxicity by regulating the AKT\/mTOR\/autophagy pathway","volume":"469","author":"He","year":"2022","journal-title":"Toxicology"},{"key":"10.1016\/j.phrs.2026.108196_bib51","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2006.06.057","article-title":"SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells","volume":"126","author":"Haigis","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2026.108196_bib52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10545-017-0069-8","article-title":"Loss of sirtuin 4 leads to elevated glucose- and leucine-stimulated insulin levels and accelerated age-induced insulin resistance in multiple murine genetic backgrounds","volume":"41","author":"Huynh","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.phrs.2026.108196_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113661","article-title":"Ginsenoside Rb3 upregulates sarcoplasmic reticulum Ca(2+)-ATPase expression and improves the contractility of cardiomyocytes by inhibiting the NF-\u03baB pathway","volume":"154","author":"Shao","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2026.108196_bib54","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.3892\/etm.2017.4280","article-title":"Ginsenoside Rb3 strengthens the hypoglycemic effect through AMPK for inhibition of hepatic gluconeogenesis","volume":"13","author":"Meng","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.phrs.2026.108196_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103184","article-title":"Sirt5 improves cardiomyocytes fatty acid metabolism and ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation","volume":"73","author":"Wu","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2026.108196_bib56","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.yjmcc.2019.11.159","article-title":"Defining decreased protein succinylation of failing human cardiac myofibrils in ischemic cardiomyopathy","volume":"138","author":"Ali","year":"2020","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.phrs.2026.108196_bib57","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/CIRCRESAHA.120.317933","article-title":"Targeting mitochondria-inflammation circuit by \u03b2-hydroxybutyrate mitigates HFpEF","volume":"128","author":"Deng","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2026.108196_bib58","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart failure with preserved ejection fraction: a review","volume":"329","author":"Redfield","year":"2023","journal-title":"JAMA"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T22:28:27Z","timestamp":1778020107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826001118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":58,"alternative-id":["S1043661826001118"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108196","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SIRT4-mediated debutyrylation of SUCLG1 rescues myocardial energy failure in HFpEF: Ginsenoside Rb3 as a novel SIRT4-interacting regulator","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108196"}}